2017•PubMedOpen access

Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients.

Saeedeh Mousavi, Leila Kohan, Majid Yavarian, Asadollah Habib

Open full text 14 citations

Abstract

GG), patients with A allele had highest HbA1C reduction in response to metformin.

About this research paper

What this paper is about

GG), patients with A allele had highest HbA1C reduction in response to metformin.

Why it matters

OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

GG), patients with A allele had highest HbA1C reduction in response to metformin.

Key concepts: Metformin, Pharmacogenetics, Type 2 diabetes, Medicine, Genotype, Diabetes mellitus, Internal medicine, Allele

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients. — Research Paper | ScholarLens